Beattie announces $473m funding boost
Tuesday, 19 April, 2005
Queensland's Beattie Government has announced AUD$473 million in new funding for the second phase of its Smart State Strategy.
Premier Peter Beattie announced the funding would include $350.8 million in recurrent spending, and $121.7 million in capital.
Last week, the Premier announced the government would invest $7 million towards a scale-up manufacturing facility for the state's biotechnology and pharmaceutical companies.
He also announced a $1.4 funding commitment to a new biotechnology commercial pipeline to help biotech companies attract venture capital and market their products overseas.
More than $200 million will be delivered over the next four years to build new research infrastructure and support innovation via three newly created funds:
- a $128 million innovation building fund
- a $12 million innovation skills fund, to attract and retain leading interstate and international researchers and PhD students to Queensland
- A $60 million innovation projects fund, to support R&D and innovation, matching institutional investment dollar for dollar
-
The government also announced it will add $20 million to the fourth and final round of the Smart State Research Facilities fund, and establish a new Golden Casket Medical Research Foundation, in conjunction with the Golden Casket Lottery Corporation.
The research foundation will apply an estimated $1.3 million in interest from $23 million in unclaimed Golden Casket and Powerball lottery wins, to health and medical research.
Other Smart State biotechnology initiatives include $4 million for the aquaculture industry and $1 million for biotechnology research to control cane toads.
More effective antibiotic found for Lyme disease
Researchers have found that piperacillin, an antibiotic in the same class as penicillin,...
Why do our waistlines expand in middle age?
A new preclinical study highlights the importance of controlling new fat-cell formation to...
Anti-inflammatory drug may help treat alcohol use disorder
A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...